A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This is a non-randomised, single arm, open-label study of medical cannabis, Cybis™ 10:25, in
participants with chronic back or neck pain in which participants receive escalating doses of
Cybis™ 10:25.